Instrument Inactif

Autres langues Medivation Inc

Actions

US58501N1019

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

28/10/16	Sanofi : relève ses prévisions pour 2016 et s'envole en Bourse	DJ
28/10/16	Sanofi : relève ses prévisions pour 2016 et veut céder ses activités génériques en Europe	DJ

Autres langues

28/10/16	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat
10/10/16	Medivation : Neue, im Rahmen der ESMO 2016 präsentierte Ergebnisse belegen zusätzlich, dass XTANDITM▼ (Enzalutamid) die Zeit bis zur PSA-Progression bei fortgeschrittenem Prostatakarzinom im Vergleich zu Placebo signifikant verlängert
09/10/16	Medivation : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo
09/09/16	Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit Against Medivation, Inc.
07/09/16	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources
06/09/16	MEDIVATION SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Medivation, Inc. (MDVN) Over the Proposed Sale of the Company to Pfizer Inc.
26/08/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
25/08/16	Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. for $81.50 Per Share is Fair to Shareholders
24/08/16	SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Medivation, Inc. -MDVN
23/08/16	Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. to Pfizer Inc. is Fair to Shareholders
22/08/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information
22/08/16	Medivation, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Pfizer Inc.
22/08/16	MEDIVATION, INC. Rigrodsky & Long, P.A. Announces Investigation Of Buyout
22/08/16	Pfizer bietet Milliarden für Biopharmaspezialisten Medivation
22/08/16	Amgen : Pfizer kauft US-Krebsspezialisten Medivation für 14 Milliarden Dollar
22/08/16	US-Pharmakonzern Pfizer bietet Milliarden für Biopharmaspezialist Medivation
22/08/16	Kreise: Pfizer mit Medivation vor Milliardendeal - Sanofi geht leer aus
29/07/16	Sanofi belastet von Wechselkursen und Venezuela - Übernahme im Fokus
29/07/16	Medivation : Preisdruck in USA schmälert Gewinn von Pharmakonzern Sanofi
08/07/16	Abbott Laboratories : Medtech's 2016 stock surge confronts second-quarter test
06/07/16	Purcell Julie & Lefkowitz LLP Is Investigating Medivation, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
06/07/16	REMINDER: Medivation to Host Conference Call and Webcast Providing Detailed Review of Talazoparib on July 6, 2016
05/07/16	Medivation : Enters into Confidentiality Agreements, Including with Sanofi
24/06/16	Medivation : Glass Lewis Recommends Medivation's Stockholders Support the Company's Current Board
24/06/16	Medivation : Glass Lewis Recommends Medivation’s Stockholders Support the Company’s Current Board